
The Peter Attia Drive #114 - Eileen White, Ph.D.: Autophagy, fasting, and promising new cancer therapies
55 snips
Jun 8, 2020 Eileen White, Chief Scientific Officer at the Rutgers Cancer Institute and a leading expert in autophagy, shares her groundbreaking insights on the role of autophagy in health and cancer. She discusses how autophagy can paradoxically help cancer cells survive, revealing new avenues for therapies. Eileen also examines the potential of fasting and specific molecules, like rapamycin and metformin, to enhance autophagy for longevity and disease prevention. The complexity of autophagy’s dual role in cancer growth and protection adds depth to the conversation.
AI Snips
Chapters
Transcript
Episode notes
Measuring Autophagy
- Measure autophagy's signature using metabolites as surrogate markers in humans.
- This approach is necessary due to the lack of tools for direct autophagic flux measurement.
Quantifying Autophagy
- Machine learning could analyze various metabolites and proteomic data to quantify autophagy.
- A study involving blood draws and muscle biopsies at different fasting stages could provide valuable insights.
Fasting's Metabolic Impact
- Fasting triggers complex metabolic changes, including glycogen mobilization, triglyceride breakdown, and muscle protein degradation.
- Understanding these dynamics is crucial for comprehending the effects of fasting.
